Alpha-Gal Syndrome Allergy to Intravitreal Administration of Anti-Vascular Endothelial Growth Factor Agents. [PDF]
Zhang E, Bylund R, Zhang A, Massop D.
europepmc +1 more source
Inhibition of Corneal Neovascularization by Subconjunctival Bevacizumab in an Animal Model
Purpose: To evaluate the effect of subconjunctival injection of bevacizumab on experimentally induced corneal neovascularization. Design: Experimental animal study. Methods: Twelve New Zealand white rabbits were involved, divided equally into four groups.
Giamarellos-Bourboulis, E.J. +5 more
core
Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]
Mishra C +4 more
europepmc +1 more source
An Atypical Presentation of Disseminated Intravascular Coagulation Following Ocular Interventions for Proliferative Diabetic Retinopathy: Mimicking Retrobulbar Hemorrhage. [PDF]
AlTayash SF +5 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapy in uveitis: Bridging inflammation and vascular pathology. [PDF]
Kawali A +3 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapies in ophthalmology. [PDF]
Koksaldi S, Karti O, Saatci AO.
europepmc +1 more source
Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies. [PDF]
Muller E +3 more
europepmc +1 more source
First-in-Human Clinical Evaluation of a Novel Nonsurgical Suprachoroidal Delivery Approach for Triamcinolone in Diabetic Macular Edema. [PDF]
Barak Y +4 more
europepmc +1 more source
The Effect of Subconjunctival Bevacizumab Injection before Conjunctival Autograft for Pterygium
Yong Il Kim +5 more
openaire +1 more source
Interferon as a novel agent for management of macular edema: Where do we stand? [PDF]
Kawali A +4 more
europepmc +1 more source

